Federal Form 6765

Federal Form 6765 is the primary federal document used to calculate and claim the Credit for Increasing Research Activities under Internal Revenue Code Section 41. In the New Jersey tax landscape, it provides the essential methodological framework for determining the state-level Research and Development Tax Credit claimed on Form 306.

The relationship between the Internal Revenue Service (IRS) and the New Jersey Division of Taxation regarding research and development (R&D) incentives is one of structured dependency and strategic alignment. While New Jersey relies heavily on federal definitions of what constitutes “qualified research,” the state has increasingly asserted its fiscal sovereignty by decoupling from certain federal restrictions to foster a more competitive environment for technology and life sciences. This report examines the technical meaning of Form 6765, its mandatory role in New Jersey tax compliance, the specific state guidance that governs its application, and the broader economic implications for corporations operating within the Garden State.

Technical Foundations of Federal Form 6765

Federal Form 6765, titled “Credit for Increasing Research Activities,” serves as the quantitative and, more recently, qualitative anchor for taxpayers claiming R&D incentives. Its primary purpose is to allow taxpayers to calculate the credit allowed under Section 41 and to make critical elections that dictate the tax treatment of research expenditures.

The Four-Part Test and Business Component Definitions

For an activity to be reported on Form 6765, it must satisfy the “Four-Part Test” as defined under Internal Revenue Code (IRC) Section 41(d). This test is the universal standard adopted by New Jersey to determine if an activity qualifies for state-level credits.

Test Component	Definition and Requirement
Technological in Nature	The research must fundamentally rely on principles of physical or biological science, engineering, or computer science.
Permitted Purpose	The activity must relate to a new or improved function, performance, reliability, or quality of a business component.
Elimination of Uncertainty	The research must be intended to discover information to eliminate technical uncertainty regarding the capability, method, or design of a product or process.
Process of Experimentation	Substantially all (80% or more) of the activities must involve a systematic process of evaluating alternatives through modeling, simulation, or trial and error.

A “business component” is defined as any product, process, software, technique, formula, or invention held for sale, lease, or license, or used in the taxpayer’s trade or business. New Jersey law incorporates these definitions by reference, ensuring that any expenditure qualified at the federal level is eligible for the New Jersey credit, provided the research is conducted within the state’s borders.

Recent Reporting Evolutions: Sections E and G

The IRS has recently expanded Form 6765 to include more qualitative data, a shift that has significant implications for New Jersey taxpayers who must attach the federal form to their state returns.

For tax years beginning in 2024, Section E was introduced to capture “Other Information,” such as the total number of business components, the amount of officer wages included in the claim, and any acquisitions or dispositions made during the year. Section G, which becomes mandatory for most filers starting in tax year 2026 (after being optional for 2024 and 2025), requires detailed project-level reporting.

Requirement Category	Section G Detail	Compliance Deadline
Business Component Reporting	Identification of at least 80% of QREs by name and type.	Mandatory for TY 2026+.
Wage Breakdowns	Allocation of wages into direct research, direct supervision, and direct support.	Mandatory for TY 2026+.
Exemptions	Taxpayers with QREs ≤ $1.5M and gross receipts ≤ $50M at the controlled group level.	Available on original returns.

These changes represent an intensification of documentation standards. New Jersey revenue officers now have access to granular federal data that can be used to identify discrepancies in state-level claims, particularly regarding the location of research activities.

The New Jersey Research and Development Tax Credit: Statutory Framework

The New Jersey Research and Development Tax Credit is codified under N.J.S.A. 54:10A-5.24. This statute provides a credit against the Corporation Business Tax (CBT) for qualifying research activities performed within New Jersey.

Core Provisions and Credit Rates

The New Jersey credit is calculated as the sum of two components, both utilizing a flat 10% rate, which differs from the federal tiered structure.

1. Qualified Research Expenses (QREs): 10% of the excess of New Jersey QREs for the privilege period over a calculated base amount.
2. Basic Research Payments: 10% of basic research payments (contributions) made to qualified organizations, such as New Jersey-based universities or energy research consortia.

The “base amount” is a critical calculation component. For the regular credit method, it is the product of the taxpayer’s fixed-base percentage (capped at 16%) and the average annual gross receipts for the four preceding tax years. Under no circumstances can the base amount be less than 50% of the current-year QREs.

New Jersey Revenue Office Guidance: TB-114 and N.J.A.C. 18:7-3.23

The New Jersey Division of Taxation provides comprehensive guidance through Technical Bulletin TB-114 and administrative rules in N.J.A.C. 18:7-3.23. This guidance clarifies that the New Jersey credit is “nonrefundable” and cannot reduce a corporation’s tax liability below the statutory minimum tax.

The Division mandates that for tax years beginning on and after January 1, 2018, taxpayers must use the same method (Regular vs. Alternative Simplified Credit) for New Jersey purposes that was used for federal purposes on Form 6765.

Filing Requirement	Detail and Regulation
Form 306	The mandatory New Jersey form for claiming the R&D credit.
Electronic Filing	All CBT returns and credit schedules must be submitted electronically.
Federal Attachment	A complete copy of federal Form 6765 must be attached to the CBT return.
Method Consistency	Taxpayers cannot use the Regular method for federal and ASC for state.

If the IRS makes adjustments to the amount of qualifying expenses during an audit, the taxpayer is required by N.J.A.C. 18:7-3.23A(h) to file an amended New Jersey return reflecting those changes within the prescribed statute of limitations.

Methodological Synchronization: Applying Form 6765 to Form 306

The choice of calculation method on Form 6765—either the Regular Credit (Section A) or the Alternative Simplified Credit (ASC) (Section B)—dictates the path a taxpayer must follow on New Jersey Form 306.

The Regular Credit Method (Form 306, Part III)

The Regular method is based on a historical comparison of research intensity. It is often favored by mature companies with established research programs. In this method, the New Jersey base amount calculation mirrors the federal logic but is restricted to New Jersey gross receipts.

For New Jersey purposes, gross receipts must be reduced by returns and allowances to the extent they would be reduced for the federal calculation. Start-up companies utilize a fixed-base percentage of 3% for the first five years, which gradually phases into a higher percentage based on actual New Jersey performance.

The Alternative Simplified Credit (ASC) Method (Form 306, Part IV)

The ASC method is frequently selected by companies that lack consistent historical data or those with volatile R&D spending patterns. Since 2018, New Jersey has fully embraced the ASC method, provided it is elected on federal Form 6765.

ASC Calculation Step	New Jersey Application
Total Prior QREs	Sum of New Jersey QREs for the three preceding taxable years.
Average QREs	Total Prior QREs divided by 3.
Base Amount	50% of the Average QREs (effectively Prior Total / 6).
Credit Calculation	10% of the amount by which current NJ QREs exceed the Base Amount.

The consistency requirement is absolute: changing methods requires amending both the federal and state returns, and New Jersey does not allow a taxpayer to deviate from the federal choice in a given tax year.

Strategic Decoupling: New Jersey’s Competitive Divergence

One of the most critical aspects for professional tax planning in New Jersey is the state’s decision to decouple from several restrictive federal provisions. This decoupling makes New Jersey a significantly more attractive location for R&D than states that strictly conform to the federal code.

IRC Section 174: Amortization vs. Expensing

Under the Tax Cuts and Jobs Act (TCJA), federal law began requiring the amortization of R&D expenses over five years (domestic) or fifteen years (foreign) for tax years beginning after December 31, 2021. Recognizing the burden this placed on cash flow, New Jersey enacted P.L. 2023, c. 96 to decouple from this requirement.

The New Jersey Division of Taxation confirms that taxpayers claiming the New Jersey R&D credit can also deduct those expenditures on their CBT return in the same year they are incurred. This immediate expensing is a major benefit for tech and biotech firms.

1. Retroactive Effect: The decoupling is retroactively effective for tax years ending on or after July 31, 2022.
2. Reporting: These deductions are recorded as “other deductions” on Schedule A, Part II of the CBT return.
3. Amended Returns: Taxpayers who previously amortized New Jersey expenses on their 2022 filings are permitted to file amended returns to claim the immediate deduction.

IRC Section 280C and 280E Exceptions

At the federal level, taxpayers must elect a “reduced credit” on Form 6765 (Item A) under Section 280C to avoid reducing their expense deductions. New Jersey does not require such a trade-off. A taxpayer can claim the full 10% state credit without being forced to reduce their deduction for those same expenditures for CBT purposes.

Furthermore, New Jersey has decoupled from IRC Section 280E for licensed cannabis businesses. While these businesses are barred from federal R&D credits on Form 6765, New Jersey P.L. 2023, c. 50 allows them to claim the New Jersey R&D credit and deduct related expenses, provided they meet all other state requirements.

Qualified Research Expenditures (QREs): The New Jersey Nexus

To be eligible for the New Jersey credit, expenses must not only meet the federal Section 41 criteria but must also be specifically tied to activities performed within the state of New Jersey.

Categories of Qualifying Costs

The Division of Taxation identifies four primary categories of QREs that align with federal Form 6765 but must be New Jersey-sourced.

• Wages: Salaries and stock options for employees directly performing, supervising, or supporting research in New Jersey.
• Supplies: Materials, prototypes, and laboratory chemicals consumed during experimentation in New Jersey.
• Contract Research: 65% of payments made to third parties for research services performed within New Jersey.
• Computer Leasing: Costs for leasing or renting computer equipment used directly in qualifying New Jersey research.

Apportionment for Multi-State Activities

If a taxpayer conducts research both within and outside New Jersey and cannot precisely quantify the New Jersey portion, N.J.A.C. 18:7-3.23A(j) allows for an allocation methodology. This typically involves applying a ratio of New Jersey-based research payroll to total research payroll, or another reasonable method approved by the Director of the Division of Taxation.

Expenditure Type	Source Requirement	Inclusion Rate
In-House Wages	Employees physically in NJ.	100% of NJ-sourced wages.
Supplies	Consumed in NJ labs.	100% of cost.
Contract Research	Work performed in NJ.	65% of payment.
Basic Research	Paid to NJ Universities.	100% of payment.

Monetizing Credits: The NJEDA Technology Business Tax Certificate Transfer Program

For unprofitable technology and biotechnology firms, the R&D credit is an asset that can be converted into immediate cash through the NJEDA’s certificate transfer program, often called the Net Operating Loss (NOL) Program.

Program Mechanics and Impact

Eligible companies can sell their unused New Jersey R&D tax credits for at least 80% of their face value to other New Jersey corporate taxpayers. This provides critical growth capital for firms that have not yet reached profitability but are investing heavily in innovation.

Metric	NJEDA Program Detail
Annual Pool	$75 Million.
Strategic Reserves	$15 Million for Innovation/Opportunity Zones and M/WBEs.
Firm Cap	$20 Million lifetime maximum.
Application Deadline	June 30 of each year.
Survival Rate	72% for program participants (industry avg. is 36%).

The capital raised must be used for salaries, R&D, and other working capital expenditures. This program has historically supported over 600 companies, creating a significant economic multiplier for the state.

Statistical Overview and Economic Outlook

The R&D tax credit is one of the most significant tax expenditures in New Jersey. According to the 2024 Tax Expenditure Report, the state expects to forgo $359.1 million in revenue in 2025 to support this credit.

Sector-Specific Impacts

The New Jersey economy is heavily reliant on “Priority Industries” that benefit most from the R&D credit, particularly those granted a 15-year carryforward rather than the standard 7-year period.

Industry Field	Extended Carryforward (15 yrs)	Economic Significance
Biotechnology	Yes.	$28.1B economic impact since 1999.
Advanced Computing	Yes.	Core of Newark’s tech hub.
Medical Devices	Yes.	High concentration in Central NJ.
Clean Technology	Yes.	Subject of specialized seed grant programs.

The 2025 Corporate Business Tax revenue is projected to decline by 15%, partly due to the high volume of credits being claimed as businesses capitalize on the new decoupling rules and the expiration of the 2.5% CBT surtax.

Comprehensive Example: R&D Credit Calculation and Application

To illustrate the practical application of federal Form 6765 methodology to the New Jersey CBT-100 return, consider a mid-sized biotechnology firm located in Newark, NJ.

Step 1: Federal Election on Form 6765

The firm elects the Alternative Simplified Credit (ASC) method on its federal return to avoid the burden of historical mid-80s recordkeeping.

• Current Year (2024) QREs: $3,000,000 (all New Jersey-sourced).
• Prior 3-Year QREs (2021-2023): $1,200,000 (average of $400,000/year).
• Basic Research Payment (to NJIT): $100,000.

Step 2: New Jersey Calculation on Form 306

Because the ASC method was used federally, the taxpayer must complete Part IV of New Jersey Form 306.

Calculation Component	Formula / Step	Amount
Average Prior QREs	$1,200,000 / 3	$400,000
Base Amount	$400,000 * 50%	$200,000
Excess QREs	$3,000,000 – $200,000	$2,800,000
QRE Credit (10%)	$2,800,000 * 0.10	$280,000
Basic Research Credit (10%)	$100,000 * 0.10	$10,000
Total NJ R&D Credit	QRE + Basic Research	$290,000

Step 3: Application to CBT Liability

The firm has a 2024 CBT liability of $150,000. Under N.J.S.A. 54:10A-5.24, the credit cannot reduce the tax below the statutory minimum. Assuming a minimum tax of $2,000:

1. Credit Used: $148,000 (reducing liability to $2,000).
2. Unused Credit: $142,000 ($290,000 – $148,000).
3. Carryforward: Because this is a biotechnology firm, the $142,000 can be carried forward for 15 years to offset future CBT liability.

Final Thoughts: The Imperative of Meticulous Documentation

The New Jersey Research and Development Tax Credit is a powerful fiscal tool, but its successful utilization depends on precise alignment with federal standards. The mandatory attachment of Form 6765 to the state return ensures that New Jersey revenue officers have full visibility into the taxpayer’s federal positions. With the IRS transitioning toward more detailed project-level reporting in Section G, the importance of contemporaneous documentation has never been higher.

New Jersey’s strategic decision to decouple from Section 174 amortization and Section 280C deduction reductions provides a unique cash-flow advantage. However, this advantage is only secure if the underlying research activities are thoroughly documented to withstand both federal and state audits. Taxpayers should focus on mapping their New Jersey QREs directly to the business components identified on Form 6765, ensuring that every dollar of claimed credit is substantiated by a clear record of technological uncertainty and scientific experimentation. As the state moves toward even greater incentives for priority industries, those who master the technical nuances of the Form 6765-Form 306 relationship will be best positioned to drive innovation and economic growth in the Garden State.